Nektar Therapeutics (NKTR) Inventory (2010 - 2024)

Nektar Therapeutics' Inventory history runs 15 years deep, the most recent figure standing at $14.5 million for Q2 2024.

• In Q2 2024, Inventory fell 30.08% year-over-year to $14.5 million; the TTM figure through Jun 2024 stood at $14.5 million (down 30.08% YoY), while the FY2023 annual figure was $16.1 million, down 16.15% from the prior year.
• Inventory for Q2 2024 stood at $14.5 million, down from $16.2 million in the prior quarter.
• The five-year high for Inventory was $20.7 million in Q2 2023, with the low at $12.6 million in Q2 2020.
• The 5-year median for Inventory is $15.6 million (2021), against an average of $16.2 million.
• The sharpest annual moves came in 2023 and 2024: Inventory surged 31.58% in 2023, then sank 30.08% in 2024.
• Nektar Therapeutics' Inventory stood at $15.3 million in 2020, then grew by 3.33% to $15.8 million in 2021, then gained by 21.52% to $19.2 million in 2022, then decreased by 16.15% to $16.1 million in 2023, then declined by 10.16% to $14.5 million in 2024.
• Business Quant data shows NKTR's Inventory at $14.5 million in Q2 2024, $16.2 million in Q1 2024, and $16.1 million in Q4 2023.